Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2016 May 6;6:25426. doi: 10.1038/srep25426

Utilization of Microemulsions from Rhinacanthus nasutus (L.) Kurz to Improve Carotenoid Bioavailability

Nai-Hsing Ho 1, Baskaran Stephen Inbaraj 1, Bing-Huei Chen 1,a
PMCID: PMC4858739  PMID: 27150134

Abstract

Carotenoids have been known to reduce the risk of several diseases including cancer and cardiovascular. However, carotenoids are unstable and susceptible to degradation. Rhinacanthus nasutus (L.) Kurz (R. nasutus), a Chinese medicinal herb rich in carotenoids, was reported to possess vital biological activities such as anti-cancer. This study intends to isolate carotenoids from R. nasutus by column chromatography, identify and quantify by HPLC-MS, and prepare carotenoid microemulsions for determination of absolute bioavailability in rats. Initially, carotenoid fraction was isolated using 250 mL ethyl acetate poured into an open-column packed with magnesium oxide-diatomaceous earth (1:3, w/w). Fourteen carotenoids including internal standard β-apo-8′-carotenal were resolved within 62 min by a YMC C30 column and gradient mobile phase of methanol-acetonitrile-water (82:14:4, v/v/v) and methylene chloride. Highly stable carotenoid microemulsions were prepared using a mixture of CapryolTM90, Transcutol®HP, Tween 80 and deionized water, with the mean particle being 10.4 nm for oral administration and 10.7 nm for intravenous injection. Pharmacokinetic study revealed that the absolute bioavailability of carotenoids in microemulsions and dispersion was 0.45% and 0.11%, respectively, while a much higher value of 6.25% and 1.57% were shown for lutein, demonstrating 4-fold enhancement in bioavailability upon incorporation of R. nasutus carotenoids into a microemulsion system.

Carotenoids, a group of lipid-soluble compounds with color ranging from yellow to red, can be divided into carotenes and xanthophylls, with the former containing only hydrocarbons and the latter being oxygenated derivatives1. Several epidemiological studies have shown that diets rich in carotenoid-containing foods are associated with reduced risk of certain types of chronic diseases such as cancer, cardiovascular disease, age-related macular degeneration and cataracts2,3,4,5,6. However, due to presence of long-chain conjugated double bonds, carotenoids are susceptible to degradations when exposed to oxygen, heat, light and acid, which in turn result in a low bioavailability in vivo7,8. For instance, O’Neill and Thurnham9 compared absorption efficiency of dietary supplements β -carotene (40 mg), lycopene (38 mg), and lutein (31.2 mg) in human, and reported that only 1.4 mg (3.5%), 1 mg (2.6%) and 0.8 mg (2.6%) were absorbed, respectively. Nevertheless, through development of a microemulsion or nanoemulsion technique for encapsulation of unstable carotenoids to enhance stability and bioavailability in vivo is feasible8. Compared to single intake of high-dose carotenoids, the multiple intakes of low-dose carotenoids were shown to provide a higher absorption efficiency10. In addition, through treatments of heat, mechanical force or enzyme, carotenoids in food matrix could be released faster to enhance bioavailability in vivo11. After release, the enzymatic hydrolysis of triglycerides by lipase for subsequent interaction with biliary salts for micelle formation is necessary, followed by transport to enterocyte membrane by simple diffusion or SR-B1 mediated transport, and chylomicron assembly for circulation to liver via lymphatic system11,12. In a previous study we demonstrated that through preparation of lycopene micelle and lycopene chylomicron, the absolute bioavailability of lycopene could be enhanced greatly, with the latter being higher than the former8.

Rhinacanthus nasutus (L.) Kurz (R. nasutus) is a well-known Chinese medicinal herb widely grown in Asian countries such as Taiwan and China, and often sold as “healthy beverage” on the market13. Several vital biological activities including anti-cancer14, anti-bacteria15 and anti-inflammation16 for consumption of R. nasutus have been well documented, which can be attributed to presence of various functional compounds like carotenoids, flavonoids, phenolic acids, chlorophylls, and napthoquinones13,17,18,19. Of various functional compounds, the carotenoid composition in R. nasutus has been thoroughly studied by Kao et al.18 and reported a total amount of 2195 μ g/g and 1576 μ g/g in freeze-dried and hot-air-dried samples, respectively. More specifically, all-trans forms of α -carotene, β -carotene, β -cryptoxanthin, lutein, neoxanthin and violaxanthin as well as their cis isomers were shown to be present, with all-trans-β -carotene dominating followed by all-trans-lutein and all-trans-α -carotene18. Regarding their biological significance, α -carotene and β -carotene are vitamin A precursors, while lutein has been demonstrated to be closely associated with prevention of age-related macular degeneration12,20. Thus, carotenoid-rich R. nasutus was chosen as a natural source for isolation and preparation of carotenoid microemulsion. By incorporating the carotenoid extract from R. nasutus into a microemulsion system, the bioavailability could be enhanced thereby reducing the dose substantially. Also, the unstable nature of carotenoids could be remedied. Most importantly, the bioavailability could be greatly enhanced by modifying the overall formula of R. nasutus healthy drink through incorporation of R. nasutus-derived carotenoid microemulsion.

Microemulsion belongs to a transparent or semi-transparent and thermodynamically stable emulsion, which can be formed by two immiscible liquids, oil and water, in the presence of surfactant or co-surfactant21. Due to the presence of extremely small droplets (<100 nm) in microemulsion, the phase separation phenomenon will not occur even after long-time storage. Though nanoemulsion systems are kinetically stable, they are not thermodynamically stable as microemulsions21. As only a few reported studies deal with bioavailability of carotenoid microemulsion and no information is available on bioavailability of R. nasutus-derived carotenoid microemulsion, the objectives of this study were to develop an open-column chromatographic method for isolation and preparation of carotenoids from R. nasutus. Then the various carotenoids were identified and quantified by HPLC-MS, followed by preparation of carotenoid microemulsion for oral bioavailability determination of both lutein and carotenoid using rats as an animal model.

Results and discussion

HPLC analysis of carotenoids

Figure 1 shows HPLC chromatogram of carotenoids prepared from R. nasutus extract by open-column chromatography. A total of 14 carotenoids including internal standard β -apo-8′-carotenal were resolved within 62 min, with the retention factor (k) ranging from 1.16–14.73, separation factor (α ) from 1.03–2.27, and peak purity from 91.5–99.9% (Table 1), implying a proper solvent strength and selectivity of mobile phase to sample components was controlled. It has been well established that the k value should be controlled between 1–10 or 1–20 and α values higher than 1 to attain a satisfactory separation22. Nevertheless, several carotenoid peaks were partially overlapped in Fig. 1 and the complete resolution of all-trans forms of carotenoids and their geometrical isomers (cis-forms) has been difficult even with a C30 column, which may be due to highly complex nature of functional compounds present in herbs like R. nasutus. Furthermore, due to unavailability of cis-forms standards of carotenoids, the identification of cis-carotenoids by mass spectrometer is impossible. To overcome this problem, a method of photoisomerization of all-trans carotenoids was adopted for further identification of cis-carotenoids18. Figure 2 shows HPLC chromatograms of standards of all-trans forms of lutein (A), β -cryptoxanthin (B), α -carotene (C) and β -carotene (D) after illumination at 25 °C for varied length of time. A total of three cis isomers of lutein (cis-lutein and 13- or 13′-cis-lutein), two cis isomers of β -cryptoxanthin (9- and 9′ -cis-β -cryptoxanthin), three cis isomers of α -carotene (9- or 9′-cis-α -carotene and 13- or 13′-cis-α -carotene), three cis isomers of β -carotene (9- or 9′-cis-β -carotene, 13- or 13′ -cis-β -carotene and 15- or 15′-cis-β -carotene), as well as β -carotene-5,6-epoxide were identified based on absorption spectra and mass spectra characteristics (Fig. 2). In addition, neoxanthin and violaxanthin prepared from spinach by thin-layer chromatography (TLC) was also used for identification (See Supplementary Materials)18. On the basis of the identification and quantitation criteria as described in the method section, all-trans-β -carotene was found to be present in the largest amount (144 μ g/mL) in R. nasutus extract, followed by all-trans-lutein (50.3 μ g/mL), all-trans-α -carotene (49.2 μ g/mL), cis isomers of β -carotene (35.1 μ g/mL), cis isomers of lutein (8.94 μ g/mL), all-trans-violaxanthin (8.26 μ g/mL), cis isomers of α -carotene (5.39 μ g/mL), all-trans-β -cryptoxanthin (1.99 μ g/mL), and all-trans-neoxanthin (1.03 μ g/mL) (Table 1). However, no cis isomers of β -cryptoxanthin, neoxanthin and violaxanthin were detected, which should be caused by presence of their corresponding trans carotenoids in small amount.

Figure 1. HPLC chromatogram of carotenoids prepared from R. nasutus extract by column chromatography.

Figure 1

Open in a new tab

The identification of peaks is the same as shown in Table 1.

Table 1. Retention time (tR), retention factor (k), separation factor (α), peak purity (pp) and contents of various carotenoids in carotenoid fraction isolated from R. nasutus extract along with their absorption and mass spectra data for identification.

Peak No. Carotenoid tR (min) k α pp (%) Absorption data (nm)
 Mass data (m/z)i
 Content (μ g/mL)
Online λmaxf Reported λmaxh Online [M + H]+ Reported [M + H]+h
1 all-trans-neoxanthina 8.25 1.16 2.27 (1, 2)e 98.8 418 440 468 418 440 468 601 601 1.03  ±   0.01
2 all-trans-violaxanthina 13.88 2.63 1.54 (2, 3)e 96.4 416 440 468 416 440 468 601 601 8.26  ±   0.74
3 13- or 13′ -cis-luteinb 19.35 4.07 1.09 (3, 4)e 95.6 416 440 464 416 438 464 569 569 5.59  ±   0.88
4 13- or 13′ -cis-luteinb 20.73 4.43 1.14 (4, 5)e 91.5 414 438 466 414 438 466 569 569 3.35  ±   0.78
5 all-trans-luteinc 23.07 5.04 1.50 (5,IS)e 99.3 424 446 474 422 446 474 569 569 50.3  ±   2.69
6 β -apo-8′ -carotenal (IS)d 32.74 7.57 1.40 (IS, 7)e 99.4 –g 464 –g –g 464 –g 417 417 –g
7 all-trans-β -cryptoxanthinc 44.24 10.58 1.04 (7, 8)e 97.2 428 456 480 428 456 480 553 553 1.99  ±   0.91
8 13- or 13′ -cis-α -caroteneb 45.77 10.98 1.03 (8, 9)e 97.7 334 442 468 334 442 468 537 537 2.95  ±   0.32
9 13- or 13′ -cis-α -caroteneb 46.96 11.29 1.03 (9, 10)e 94.2 334 442 468 334 442 468 537 537 2.44  ±   0.06
10 15- or 15′ -cis-β -caroteneb 48.31 11.65 1.04 (10, 11)e 98.6 340 454 478 340 452 478 537 537 2.70  ±   0.15
11 13- or 13′ -cis-β -caroteneb 49.88 12.06 1.05 (11, 12)e 99.6 342 448 474 342 448 474 537 537 12.8  ±   0.92
12 all-trans-α -carotenec 52.17 12.66 1.12 (12, 13)e 99.7 424 448 476 424 450 476 537 537 49.2  ±   2.69
13 all-trans-β -carotenec 57.82 14.14 1.04 (13, 14)e 99.9 428 454 482 428 456 482 537 537 144  ±   7.78
14 9- or 9′ -cis-β -caroteneb 60.07 14.73 1.04 (13, 14)e 99.6 346 450 474 340 450 476 537 537 19.6  ±   1.34
Open in a new tab

aIdentification based on absorption and mass spectra of samples isolated from spinach by thin-layer chromatography.

bIdentification based on absorption and mass spectra of HPLC chromatogram obtained for photoisomerized all-trans standards as shown in Fig. 2.

cIdentification based on absorption and mass spectra of commercially obtained reference standards.

dInternal standard.

eNumbers in parentheses represent values between two neighboring peaks.

fA gradient mobile phase of methanol-acetonitrile-water (82:14:4, v/v/v) and methylene chloride (from 95:5, v/v to 69:31, v/v) was used.

gData not available.

hBased on a gradient mobile phase of methanol-acetonitrile-water (82:14:4, v/v/v) and methylene chloride (from 100:0, v/v to 55:45, v/v) used by Kao et al.18

im/z is mass-to-charge ratio.

Figure 2.

Figure 2

Open in a new tab

HPLC chromatograms along with absorption and mass spectra data for standards of all-trans forms of lutein (A), β -cryptoxanthin (B), α -carotene (C) and β -carotene (D) after illumination at 25 °C for varied time length.

Characteristics of carotenoid microemulsion

Figure 3A,B show particle size distribution of carotenoid microemulsion for intravenous (i.v.) injection (A) and oral administration (B) as determined by DLS, which equaled 10.7 nm and 10.4 nm, respectively. This microemulsion was successfully prepared based on a study by Zhang et al.23, reporting that CapryolTM 90 is a suitable oil-soluble solvent for curcumin and Transcutol® HP is an appropriate water-soluble co-surfactant. Furthermore, CapryolTM 90 is propylene glycol monocaprylate used in self-emulsifying systems to obtain fine dispersion for drug delivery, while Transcutol® HP is highly purified diethylene glycol monoethyl ether widely used for solubilizing poorly water-soluble drugs. Likewise, Tween 80, also known as polysorbate 80, is a nonionic surfactant and emulsifier derived from polyethoxylated sobitan and oleic acid. After various studies by following this approach, a carotenoid microemulsion was prepared by evaporating carotenoid extract to dryness under nitrogen, followed by adding 3% CapryolTM 90 to dissolve the residue, 5% Transcutol® HP, 20% Tween 80, and 72% distilled water for complete homogenization, and sonicating for 90 min. This red transparent carotenoid microemulsion at a dose of 20 mg/kg body weight (bw) was used for oral administration of animal experiment. However, for i.v. injection, the carotenoid microemulsion at a dose of 2 mg/kg bw was prepared by mixing 2% CapryolTM 90, 4% Transcutol® HP, 10% Tween 80 and 84% distilled water for complete homogenization and subsequent sonication. The difference in microemulsion composition is due to only one-tenth of carotenoid dose required for i.v. than that for oral administration8. Figure 3C,D show the TEM images of carotenoid microemulsion, indicating all the nanoparticles were well dispersed and possessed spherical shape with the average diameter being 12.1 nm, which is similar to that determined by DLS. A high encapsulation efficiency of 98.6% was obtained for carotenoid microemulsion, which is relatively higher than reported for several carotenoid nanosystems. For example, Gupta and Ghosh24 obtained only 79.6% encapsulation efficiency for β -carotene nanocapsules composed of ester-type plant sterols, flaxseed oil, calcium caseinate, sodium alginate and water, while a higher value of 89% was reported for carotenoid nanoparticles prepared using chitosan, Tween 80 and tripolyphosphate25. In another study, Xia et al.26 prepared carotenoid nanoliposome composed of cholesterol, Q10 coenzyme, Tween 80 and phosphate buffer and found that the encapsulation efficiency ranged from 90–95%. For the storage stability study, only a minor change in particle size of both microemulsions for i.v. and oral administration was observed, as evident by 11.2 nm and 11.3 nm nanoemulsion size even after a 90-day storage period, respectively (Fig. 3). The complete stability data at different intermittent storage times (15, 30, 45, 60, 75 and 90 days) can be found in the supplementary materials (Figure S3 and S4).

Figure 3.

Figure 3

Open in a new tab

Characterization of carotenoid microemulsion with particle size distribution of microemulsion used for intravenous injection (A) and oral administration (B), TEM images captured at two different magnifications (C,D) and stability data for microemulsion used for intravenous injection (E) and oral administration (F) after storage at 25 °C for 90 days.

HPLC analysis of carotenoids in rat serum

Figure 4 shows HPLC chromatograms of carotenoids in rat serum after oral administration of carotenoid dispersion (non-nano carotenoids) for 4 h (A), carotenoid microemulsions for 4 h (B) and i.v. injection of carotenoid microemulsions for 2 min (C). Only one carotenoid, 13- or 13′-cis-lutein (0.35 μ g/mL), was detected in rat serum for oral administration, which can be attributed to the instability nature of carotenoids such as neoxanthin and violaxanthin. Under acidic condition, the former could be converted to neochrome, while the latter converted to luteoxanthin or auroxanthin, accompanied by a color change from yellow to green or blue18. Also, it has been well documented that all-trans carotenoids can undergo degradation or convert to their corresponding cis isomers in vivo27,28. One of the major carotenoids in R. nasutus, all-trans-β -carotene remained undetected in rat serum for oral administration, which can be due to conversion to vitamin A. Accordingly, for oral administration, the conversion efficiency of all-trans-β -carotene to vitamin A in rats was 100%, but only 28% in humans2. Conversely, after i.v. injection for 2 min, a total of 10 carotenoids were detected, in which all-trans-β -carotene and its cis-isomers constituted the largest amount (26.0 μ g/mL), followed by all-trans-lutein and its cis isomers (14.0 μ g/mL), all-trans-α -carotene and its cis isomers (11.4 μ g/mL), and all-trans-β -cryptoxanthin (1.4 μ g/mL) (Fig. 4C). It is worth pointing out that the method validation of HPLC analysis of carotenoids in rat serum was not performed as it was carried out in our previous study27.

Figure 4.

Figure 4

Open in a new tab

HPLC chromatograms for carotenoids in rat serum collected 4 h after oral administration of carotenoid dispersion (A) and carotenoid microemulsion (B) as well as 2 min after intravenous injection of carotenoid microemulsion (C). The identification of peaks is the same as shown in Table 1.

Pharmacokinetic study

Figure 5A shows the concentration-time profile of carotenoids in rat serum after oral administration of carotenoid microemulsion and carotenoid dispersion at 20 mg/kg bw for varied length of time. No carotenoids were detected for both treatments after oral administration for 2, 5, 10 and 30 min. However, carotenoids remained undetected in rat serum until 1 h, then reached a plateau in 4 h for carotenoid dispersion and in 8 h for carotenoid microemulsion. Then the carotenoid level showed a declined trend thereafter and no carotenoids were detected in 48 h for carotenoid dispersion, but only a minor amount of carotenoids detected for carotenoid microemulsion in 48 h. Comparatively, under the same time length, a higher level of carotenoids in rat serum was shown for the microemulsion treatment than for the dispersion treatment, indicating a better absorption of the former.

Figure 5.

Figure 5

Open in a new tab

The concentration-time profile for carotenoids in rat serum after oral administration of carotenoid microemulsion and dispersion at 20 mg/kg bw (A) as well as intravenous injection at 2 mg/kg bw (B).

Figure 5B shows the concentration-time profile of carotenoids in rat serum after i.v. injection of carotenoid microemulsion at 2 mg/kg bw for varied time length. A maximum carotenoid level was shown in rat serum at the initial time point (zero point), but followed a declined tendency thereafter, and no carotenoids were detected in 48 h. As mentioned before, in our study olive oil was used to dissolve carotenoids prepared by open-column chromatography to form dispersion, which makes it difficult for i.v. injection because of high viscosity. Thus, instead, for i.v. injection, only the treatment of microemulsion was used for pharmacokinetic study.

Table 2 shows pharmacokinetic parameters of carotenoids in rat serum after oral administration of carotenoid microemulsion and carotenoid dispersion at 20 mg/kg bw. The AUC for both microemulsion and dispersion treatments were 1.83 ±  1.02 and 0.46 ±  0.29 min μ g/mL, respectively, while the Cmax were 2.20 ±  1.20 and 0.50 ±  0.20 ng/mL. Apparently the microemulsion treatment showed a significantly higher AUC and Cmax than that of dispersion treatment. In addition, a much higher t1/2 was found for the microemulsion treatment than for the dispersion treatment, which amounted to 1520 ±  731 min and 1167 ±  699 min, respectively, implying a longer blood circulation time of the former. It is worth pointing out that the longer blood circulation time is a vital biomarker for enhanced bioavailability. All in all, the oral bioavailability of carotenoid microemulsion and carotenoid dispersion was calculated to be 0.45% and 0.11%, respectively, demonstrating a higher absorption efficiency of the former. As mentioned before, the extremely low bioavailability of total carotenoids in rats can be caused by degradation and isomerization as well as conversion of provitamin A carotenoids to vitamin A.

Table 2. Pharmacokinetic parameters* of carotenoids and lutein in rat serum after oral administration of carotenoid microemulsion and dispersion at 2 and 20 mg/kg bw, respectively.

Parameters Oral administration
 Intravenous injection of microemulsion
Dispersion in oil Microemulsion
Carotenoids
 Tmax (min)b 240 480 –
 Cmax (ng/mL)c 0.50 ±  0.20 2.20 ±  1.20a 310.13 ±  30.14
 t1/2 (min)d 1167.83 ±  699.74 1520.75 ±  731.25 215.17 ±  90.19
 AUC (min μ g/mL)e 0.46 ±  0.29 1.83 ±  1.02a 40.80 ±  6.55
 Oral bioavailability (%) 0.11 ±  0.07 0.45 ±  0.25a –
Lutein
 Tmax (min)b 240 480 –
 Cmax (ng/mL)c 0.50 ±  0.20 2.20 ±  1.20a 99.87 ±  11.45
 t1/2 (min)d 1167.83 ±  699.74 1520.75 ±  731.25 15.73 ±  2.79
 AUC (min μ g/mL)e 0.46 ±  0.29 1.83 ±  1.02a 2.95 ±  0.37
 Oral bioavailability (%) 1.57 ±  1.00 6.25 ±  3.50a –
Open in a new tab

*Data expressed as mean ±  standard deviation (n =  6 for each group).

aSignificantly different (p <  0.05) data when compared with dispersion group as determined by Student’s t-test.

bTime to reach Cmax.

cMaximum serum concentration.

dTime to reach half concentration.

eArea under the concentration-time curve.

The pharmacokinetic parameters of lutein in rat serum after oral administration carotenoid microemulsion and carotenoid dispersion at 20 mg/kg bw is also shown in Table 2. The AUC of lutein for both microemulsion and dispersion treatments were 1.83 ±  1.02 and 0.46 ±  0.29 min μ g/mL, respectively, while the Cmax of lutein were 2.20 ±  1.20 and 0.50 ±  0.20 ng/mL. Also, a much higher t1/2 and Tmax was found for lutein in the carotenoid microemulsion treatment than that for the dispersion treatment. By comparison, the pharmacokinetic parameters of lutein were the same as carotenoids for both dispersion and microemulsion by oral administration, mainly because only lutein was detected after oral administration. The oral bioavailability of lutein was determined to be 6.25% and 1.57% for the carotenoid microemulsion treatment and carotenoid dispersion treatment, respectively. Comparatively, in our experiment lutein showed a much higher bioavailability than the other carotenoids in rats, which should be due to a higher stability of the former. In addition, most importantly, carotenoids in R. nasutus extract contain a high amount of α -carotene and β -carotene (Table 1), both of which can be converted to vitamin A in rats leading to a further decline in carotenoid bioavailability. Also, as mentioned above, both neoxanthin and violaxanthin were susceptible to degradations when exposed to acid in the stomach.

The absolute bioavailability of carotenoid microemulsion or nanoemulsion can be affected by many factors such as shape, size, dose, encapsulation efficiency, emulsion characteristics, formulation, etc. For example, in a recent study Chen et al.8 reported that a high dose of lycopene may cause saturation of lycopene absorption in rats. Instead, a high efficiency in lycopene absorption was shown at low dose (10 or 13 mg per day) in a human clinical trial, probably due to the presence of intestinal-binding protein to facilitate lycopene absorption29,30. In another study Salvia-Trujillo et al.31 prepared β -carotene emulsions of different size (23, 0.38 and 0.21 μ m) and reported that the smaller the size, the higher the absorption efficiency in vitro. Likewise, Wang et al.32, prepared β -carotene emulsion composed of soybean oil and decaglycerol monolaurate and demonstrated that the smaller the size, the higher the bioavailability in vitro. Compared to the other carotenoids, lutein was shown to possess a higher absorption efficiency, which can be associated with its stability and polar nature33. In addition to carotenoids, Hatanaka et al.34 prepared Q10 nanoemulsion composed of surfactant, lecithin, glycerol, and water with the average size being 60 nm, and performed the pharmacokinetic experiments in rats. The outcome showed that the Q10 nanoemulsion resulted in a 1.7-fold higher AUC and Cmax than the non-nano treatment. Similarly, Kotyla et al.35 prepared vitamin E emulsion and nanoemulsion composed of canola oil and polysorbate 80 with size being 2788 nm and 65 nm, respectively, and reported that the vitamin E concentration in rat blood was much higher for nanoemulsion than for emulsion, demonstrating again the smaller the size, the better the absorption. Interestingly, in a recent study Chen et al.8 prepared lycopene micelle and lycopene chylomicron with tomato extract as raw material with the size being 7.5 nm and 131.5 nm, respectively, based on TEM analysis, and the absolute bioavailability was determined to be 6.8% for the former and 9.5% for the latter. It was postulated that both size and shape should be taken into account for bioavailability determination as a higher bioavailability was shown for lycopene chylomicron with a thicker outer layer8. Moreover, for i.v. injection in our present study, a much smaller size of carotenoid microemulsion (12.1 nm) may evade the body’s reticuloendothelial system and penetrate into small capillaries more readily and thus the blood circulation time can be greatly extended8. Another important factor in blood circulation time extension can be attributed to a large surface area of carotenoid microemulsion which can facilitate solubilization of lipophilic carotenoids to enhance absorption21. Also, the possibility of renal excretion of carotenoid microoemulsion can be excluded as the cut-off size for renal filtration was reported to be 5.5 nm36. Conversely, a short blood-circulation time can be attributed to particles with diameter >200 nm caused by separation by mechanical filtration in the spleen and then removal by the phagocyte37. Thus, it is possible for the i.v. injection that the microemulsion will persist in the blood depending upon size, stability and time length. But for oral administration, the microemulsion will mix with bile salts and then change when they pass through the epithelium cells.

In conclusion, a preparative column chromatographic method was developed to separate carotenoids from R. nasutus extract with magnesium oxide-diatomaceous earth (1:3, w/w) as adsorbent and ethyl acetate as eluent. An HPLC gradient solvent system composed of methanol/methylene chloride/water (82:14:4) (A) and methylene chloride (B) could resolve 14 carotenoids including internal standard β -apo-8′ -carotenal within 62 min with flow rate at 1.0 mL/min and detection at 450 nm. A carotenoid microemulsion composed of CapryolTM 90, Transcuton® HP, Tween 80 and distilled water was successfully prepared with the average size being 10.4 nm and 10.7 nm for oral administration and i.v. injection, respectively. Also, the microemulsion showed a high stability over a 90-day storage period. The absolute bioavailability of carotenoid in microemulsion and dispersion was 0.45% and 0.11%, respectively. However, the absolute bioavailability of lutein in microemulsion and dispersion was much higher than carotenoid, which amounted to 6.25% and 1.57%, respectively.

Materials and methods

Materials

A total of 6 kg fresh Rhinacanthus nasutus (L.) Kurz (R. nasutus) was purchased from a local Chinese drug store located in Wan-Hua district, Taipei city. After cleaning and freeze-drying to moisture content <10%, a total of about 500 g R. nasutus was obtained and placed into separate plastic bags with 25 g each and sealed under vacuum for storage at −20 °C prior to use.

Carotenoid standards including all-trans forms of zeaxanthin, β -cryptoxanthin, α -carotene and β -carotene were purchased from Sigma (St. Louis, MO, USA), while all-trans-lutein was from Fluka Chemical Co. (Buchs, Switzerland) and all-trans-neoxanthin from Chromadex Co (CA, USA). Internal standard all-trans-β -apo-8′ -carotenal was also from Fluka Chemical Co. Both neoxanthin and violaxanthin standards were prepared from spinach by TLC using a method as described by Kao et al.18. The HPLC-grade solvents including methanol, ethanol, acetone, ethyl acetate, acetonitrile, toluene and methylene chloride were obtained from Lab-Scan Co. (Gliwice, Poland). The analytical grade solvent n-hexane was from Grand Chemical Co. (Taipei, Taiwan). Deionized water was made using a Milli-Q water purification system from Millipore Co. (Bedford, MA, USA). Magnesium oxide, potassium hydroxide and potassium phosphate were from Sigma, while diatomaceous earth was from J.T. Baker Co. (Phillipsburg, NJ, USA). Both CapryolTM 90 and Transcutol® HP were from Gattefosse Co. (Saint-Priest, France). Tween 80 was from Yi-Pa Co. (Taipei, Taiwan).

Instrumentation

The HPLC-MS system (The Agilent Technologies Co. 1200 series) is composed of a G1379B degasser, a G1312B pump, an auto sample injector (G1329B), a column temperature controller (G1316B), a photodiode-array detector (G1315C), and a 6130 quadrupole mass spectrometer with multi-mode ion source (ESI and APCI). The polymeric C30 reversed-phase column (250 ×  4.6 mm ID, 5 μ m particle size) and guard column (6 ×  4.6 mm ID) was from YMC Co. (Milford, MA, USA). The spectrophotometer (DU 640) was from Beckman Co. (Fullerton, CA, USA). The Eyela N-1 rotary evaporator was from Tokyo, Japan. The freeze-dryer was from Chin-Ming Co. (Taipei, Taiwan). The sonicator (DC400H) was from Taipei, Taiwan. The high-speed centrifuge (Sorvall RC5C) was from DuPont Co. (Wilmington, DL, USA). The micro centrifuge (Fresco 21) was from Thermo Co. (USA). The dynamic light scattering (DLS) instrument was from Brookhaven Instrument Co. (Holtsville, NY, USA). The transmission electron microscopy (TEM) (JEM-1400) was from JEOL Co. (Tokyo, Japan).

Extraction of carotenoids

A method based on Inbaraj et al.38 was used to extract carotenoids from R. nasutus samples. Initially, a 10-g powdered R. nasutus sample was mixed with 80 mL of hexane/ethanol/acetone/toluene (10:6:7:7, v/v/v/v) in a flask, after which the solution was shaken at room temperature for 1 h, followed by adding 80 mL hexane, shaking again for 10 min, and adding 30 mL anhydrous sodium sulfate (10%) for partition. The upper layer containing carotenoid was collected, while the lower layer was added with 30 mL hexane for repeated extraction until colorless. All the supernatants were pooled, evaporated to dryness and dissolved in 10-mL hexane to obtain crude carotenoid extract. After filtration through a 0.22-μ m membrane filter, a 20-μ L sample was injected into HPLC-MS for qualitative and quantitative analyses of carotenoids.

Preparation of carotenoids by open-column chromatography

A method based on Loh et al.39 was modified to isolate and prepare carotenoids from R. nasutus samples. A 3-mL carotenoid extract was poured into a glass column (400 ×  42 mm ID) containing a mixture (52 g) of magnesium oxide and diatomaceous earth (1:3, w/w), which was pre-activated with 500-mL hexane. Then anhydrous sodium sulfate was added above the adsorbent to form about 1-cm layer. Next, 25 mL of hexane (100%) was added for equilibrium, followed by adding 250 mL of ethyl acetate (100%) to elute carotenoids. The eluate was then evaporated to dryness, dissolved in 5-mL methanol/methylene chloride (3:7, v/v) and filtered through a 0.22-μ m membrane filter for HPLC analysis. The isolation of carotenoid fraction in an open-column is shown in the supplementary material (Figure S1).

HPLC analysis of carotenoids in R. nasutus extract

An HPLC method based on Kao et al.18 was modified to separate various carotenoids in R. nasutus extract by using a Waters YMC C30 column (250 ×  4.6 mm ID, 5 μ m particle size) with flow rate at 0.8 mL/min, detection at 450 nm and a mobile phase of methanol-acetonitrile-water (82:14:4, v/v/v) (A) and methylene chloride (100%) (B) with the following gradient elution: 95% A and 5% B initially, maintained for 5 min, decreased to 90% A at 8 min, 86% A at 10 min, maintained for 26 min, 70% A at 38 min, maintained for 12 min, 69% A at 52 min, maintained for 16 min, and returned to original ratio at 70 min. The various carotenoids in R. nasutus extract were identified by comparing retention times, absorption spectra and mass spectra of unknown peaks with those of reference standards. A single quadrupole mass spectrometer with APCI mode was used for detection with scanning range 400–1200 m/z, drying gas flow 7 L/min, nebulizer pressure 10 psi, dry gas temperature 330 °C, vaporizer temperature 230 °C, capillary voltage 2000 V, charging voltage 2000 V, corona current 4 μ A and fragmentor voltage 200 V. In addition, a photoisomerization method of carotenoid standards including all-trans forms of lutein, β -carotene, β -cryptoxanthin and zeaxanthin was used for further identification of cis-isomers of carotenoids (See Supplementary Materials)18. For quantitation, an internal standard β -apo-8′ -carotenal at a concentration of 10 μ g/mL was mixed with each standard solution. Various concentrations of carotenoid standards including all-trans-β -carotene (1–200 μ g/mL), all-trans-zeaxanthin (2–20 μ g/mL), all-trans-β -cryptoxanthin (1–20 μ g/mL), all-trans-α -carotene (2–80 μ g/mL), all-trans-lutein (2–80 μ g/mL and 0.1–1.5 μ g/mL), all trans-neoxanthin (1–10 μ g/mL) and violaxanthin (3.09–77.25 μ g/mL) were prepared and the standard curve of each carotenoid was drawn by plotting concentration ratio against area ratio, with the linear regression equation and correlation coefficient (R) being obtained by an EXCEL software system. For preparation of neoxanthin and violaxanthin standards, neoxanthin and violaxanthin isolated from spinach extract by TLC were quantified by spectrophotometric analysis at 439 nm and 443 nm, respectively, and were found to be 29.4 μ g/mL and 309 μ g/mL (See Figure S2 in Supplementary Materials)18. The linear regression equations of all-trans forms of neoxanthin, violaxanthin, lutein, β -cryptoxanthin, α -carotene and β -carotene were y =  2.0589x +  0.0092, y =  1.5064x−0.1768, y =  0.5524x −  0.0775, y =  2.1876x +  0.0626, y =  0.5075x +  0.0948 and y =  0.5935x +  0.2004, respectively, with R being all higher than 0.99.

Preparation of carotenoid microemulsion

A method based on Zhang et al.23 and Chen et al.8 was modified to prepare carotenoid microemulsion from R. nasutus extract. For intravenous injection (2 mg/kg bw), an appropriate amount of carotenoid extract was evaporated to dryness, followed by adding 0.2 g of CapryolTM 90, 0.4 g of Transcutol® HP, 1.0 g of Tween 80 and 8.4 g of distilled water. After mixing thoroughly, the mixture was sonicated for 90 min to obtain a 10-mL carotenoid microemulsion. For oral administration (20 mg/kg bw), a suitable amount of carotenoid extract was evaporated to dryness, followed by adding 0.3 g of CapryolTM 90, 0.5 g of Transcutol® HP, 2.0 g of Tween 80, and 7.2 g of distilled water. After mixing thoroughly, the mixture was sonicated for 90 min to obtain a 10-mL carotenoid microemulsion.

Particle size determination

The particle size distribution of carotenoid microemulsion was determined by DLS using a method as described by Chen et al.8. In the beginning the KH2PO4 (potassium dihydrogen phosphate) buffer solution was prepared by dissolving 1.7 g of KH2PO4 in 200-mL deionized water, followed by adjusting pH to 5.5 with 0.1 M potassium hydroxide, and diluting to 250 mL with deionized water. Then 100-μ L of carotenoid microemulsion was collected and diluted to 5 mL with KH2PO4 buffer solution, after which the microemulsion was filtered through a 0.2-μ m membrane filter and transferred to a polystyrene tube for determination of particle size distribution by DLS at 25 °C and the data were analyzed by a BIC particle sizing 90 plus software system. In addition to DLS, TEM was also used to determine particle size and shape based on a method by Chang and Chen40. Prior to TEM analysis, carotenoid microemulsion was diluted 50 times with deionized water, after which 20 μ L was collected and dropped onto a carbon coated 74 μ m copper grid for 30 s, followed by removing excessive sample with a glass filter paper, negative staining for 30 s with 20 μ L of 2% PTA, removing excessive stain again with a glass filter paper and drying in a dessicator for overnight. Then the TEM image was recorded by enlarging sample 3 ×  105 times under 120 kV.

Encapsulation efficiency

The encapsulation efficiency was determined based on a method reported by Chang and Chen40 by mixing 200 μ L of carotenoid microemulsion with 200 μ L of 25 mM potassium dihydrogen phosphate buffer solution (pH 5.5) and poured into a centrifuge tube equipped with a dialysis membrane (molecular weight cut-off 3 kDa) for centrifugation at 12,000 rpm for 20 min. The solution passed through the membrane was dried, followed by dissolving the residue in 100 μ L methylene chloride, adding 100 μ L of 20 ppm internal standard β -apo-8′ -carotenal dissolved in methylene chloride and injecting 20 μ L into HPLC. Based on the amount of free carotenoid, the encapsulation efficiency can be calculated using the formula as shown below:

graphic file with name srep25426-m1.jpg

Storage stability of microemulsion

Carotenoid microemulsion was stored at 25 °C for 3 months and sample was collected every 15 days for determination of particle size distribution by DLS and observation of phase separation by eye.

Animal experiment

Male Sprague-Dawley rats with body weight 230–250 g were procured from BioLASCO (Taipei, Taiwan), after which these animals were transported to Fu Jen University Laboratory Animal Center. A prior approval for using male Sprague-Dawley rats for this study was obtained from Fu Jen University animal subjects review committee. These animals were housed in ventilation cages at an ambient temperature of 21 ±  2 °C and relative humidity of 55 ±  10% for 12 h under light and 12 h in the dark. All the rats were fed with a sterilized laboratory rodent diet 5010 (LabDiet Co., St. Louis, MO, USA) ad libitum. After the body weight of all the rats reached about 280 g (8-week old), rats were ready for experiments. Also, all the 18 rats were prohibited from feeding for 12 h prior to experiments. Most importantly, the methods involving animal experiments have been carried out with the approved guidelines41.

Three treatments were used: the first (6 rats) and the second (6 rats) received oral administration of carotenoid dispersion (in oil) and microemulsion, respectively, while the third (6 rats) received i.v. injection of carotenoid microemulsion. The treatment of carotenoid dispersion by i.v. injection was not carried out because of high viscosity. For oral administration, both carotenoid dispersion and microemulsion were fed to rats separately at a dose of 20 mg/kg based on carotenoid concentration. This dose was selected based on several trials. After oral administration for 2, 5, 10 and 30 min and 1, 2, 4, 8, 24, 48 and 72 h, 0.6 mL of blood was collected from the tail vein, followed by pouring into a heparin-rinsed tube, transferring to ice bath for 30 min, and centrifuging at 5000 rpm for 15 min (4 °C). Then the supernatant was collected for subsequent carotenoid extraction and HPLC analysis. For i.v. injection, carotenoid microemulsion was injected into the temporal vein of rats at a dose of 2 mg/kg, which was one-tenth that of oral administration. After injection for 2, 5, 10 and 30 min, and 1, 2, 4, 8, 24, 48 and 72 h, 0.5 mL of blood was collected from the tail vein, followed by pouring into a heparin-rinsed tube, transferring into ice bath for 30 min, and centrifuging at 5000 rpm for 15 min at 4 °C. Then the supernatant was collected for subsequent carotenoid extraction and HPLC analysis.

HPLC analysis of carotenoids in serum

A method based on Hsu et al.27 was modified. Initially serum sample was poured into a 15-mL centrifuged tube, and 1 mL of ethanol solution containing 0.01% of ascorbic acid was added for protein precipitation and prevention of oxidation. Then 1 mL of ethyl acetate and 3 mL of hexane were added, after which the mixture was vortexed for 10 s and then shaken in a shaker for 10 min at 200 rpm. After centrifuging at 3000 rpm for 20 min at 4 °C, the supernatant was collected and 3-mL hexane was added to the lower layer 3 times for repeated extraction of carotenoids. All the supernatants were pooled, evaporated to dryness under N2, dissolved in 50-μ L methylene chloride containing internal standard parared (2 μ g/mL), filtered through a 0.22 μ m membrane filter, and 20-μ L was injected for HPLC analysis. The various carotenoids in serum samples were identified and quantified using the same approach as described above.

Pharmacokinetic study

Pharmacokinetic study was performed using a WinNonlin software system (Pharsight Co., CA, USA) by a non-compartmental model with the data expressed as mean ±  standard deviation8. The area under the drug concentration-time curve (AUC) was used to determine the total amounts of carotenoids and lutein reaching systemic circulation. In addition, some other kinetic parameters such as Tmax, Cmax and t1/2 were determined. The absolute availability of carotenoid and lutein was calculated using the following formula:

graphic file with name srep25426-m2.jpg

Statistical analysis

All the experimental data were subjected to analysis of variance and Student’s paired t-test for significance in mean comparison at p <  0.0542.

Additional Information

How to cite this article: Ho, N. H. et al. Utilization of Microemulsions from Rhinacanthus nasutus (L.) Kurz to Improve Carotenoid Bioavailability. Sci. Rep. 6, 25426; doi: 10.1038/srep25426 (2016).

Supplementary Material

Supplementary Information
srep25426-s1.doc (881.5KB, doc)

Acknowledgments

The authors wish to thank Mr Yen-Sheng Wu from Tzong Jao Hang’s Electron Microscope Laboratory, School of Medicine, Fu Jen Catholic University, Taipei, Taiwan for technical assistance in recording the transmission electron microscopic image.

Footnotes

Author Contributions B.H.C. and N.H.H. designed the experiments, N.H.H. and B.S.I. carried out the experiments and B.H.C. wrote the manuscript.

References

  1. Britton G. & Khachik F. Carotenoids in Food. In Britton G., Pfander H., Liaaen-Jensen S. (Eds.) Carotenoids. Basel: Birkhauser Publishers, pp. 45–66 (2009). [Google Scholar]
  2. Tang G. Bioconversion of dietary provitamin A carotenoids to vitamin A in humans. Am. J. Clin. Nutr. 91, 1468S–1473S (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kohlmeier L. & Hastings S. B. Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. Am. J. Clin. Nutr. 62, 1370S–1376S (1995). [DOI] [PubMed] [Google Scholar]
  4. Peters U. et al. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol. Biomarkers Prev. 16, 962–968 (2007). [DOI] [PubMed] [Google Scholar]
  5. Ciccone M. M. et al. Dietary intake of carotenoids and their antioxidant and anti-inflammatory effects in cardiovascular care. Mediators Inflamm. 2013, 782137 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Krinsky N. I. & Johnson E. J. Carotenoid actions and their relation to health and disease. Mol. Aspects Med. 26, 459–516 (2005). [DOI] [PubMed] [Google Scholar]
  7. Lee M. T. & Chen B. H. Stability of lycopene during heating and illumination in a model system. Food Chem. 78, 425–432 (2002). [Google Scholar]
  8. Chen Y. J., Inbaraj B. S., Pu Y. S. & Chen B. H. Development of lycopene micelle and lycopene chylomicron and a comparison of bioavailability. Nanotechnology 25, 155102 (2014). [DOI] [PubMed] [Google Scholar]
  9. O’Neill M. E. & Thurnham D. I. Intestinal absorption of beta-carotene, lycopene and lutein in man and women following a standard meal; response curves in the triacylglycerol-rich lipoprotein fraction. Brit. J. Nutr. 79, 149–159 (1998). [DOI] [PubMed] [Google Scholar]
  10. Goltz S. R., Sapper T. N., Failla M. L., Campbell W. W. & Ferruzzi M. G. Carotenoid bioavailability from raw vegetables and a moderate amount of oil in human subjects is greatest when the majority of daily vegetables are consumed at one meal. Nutr. Res. 33, 358–366 (2013). [DOI] [PubMed] [Google Scholar]
  11. Yonekura L. & Nagao A. Intestinal absorption of dietary carotenoids. Mol. Nutr. Food Res. 51, 107–115 (2007). [DOI] [PubMed] [Google Scholar]
  12. Fernandez-Garcia E. et al. Carotenoids bioavailability from foods: From plants pigments to efficient biological activities. Food Res. Int. 46, 438–450 (2012). [Google Scholar]
  13. Huang R. T., Lu J. F., Inbaraj B. S. & Chen B. H. Determination of phenolic acids and flavonoids in Rhinacanthus nasutus (L.) Kurz by high-performance–liquid-chromatography with photodiode-array detection and tandem mass spectrometry. J. Funct. Foods 12, 498–508 (2015). [Google Scholar]
  14. Siripong P. et al. Antitumor activity of liposomal naphthoquinone esters isolated from Thai medicinal plant: Rhinacanthus nasutus KURZ. Biol. Pharm. Bull. 29, 2279–2283 (2006). [DOI] [PubMed] [Google Scholar]
  15. Puttarak P., Charronratana T. & Panichayupakaranant P. Antimicrobial activity and stability of rhinacanthins-rich Rhinacanthus nasutus extract. Phytomedicine 17, 323–327 (2010). [DOI] [PubMed] [Google Scholar]
  16. Siriwatanametanon N., Fiebich B. L., Efferth T., Preito J. M. & Heinrich M. Traditionally used Thai medicinal plants: In vitro anti-inflammatory, anticancer and antioxidant activities. J. Ethnopharm. 130, 196–207 (2010). [DOI] [PubMed] [Google Scholar]
  17. Wu T. S., Hsu H. C., Wu P. L., Teng C. M. & Wu Y. C. Rhinacanthin-Q, a naphthaquinone from Rhinacanthus nasutus and its biological activity. Phytochemistry 49, 2001–2003 (1998). [DOI] [PubMed] [Google Scholar]
  18. Kao T. H., Chen C. J. & Chen B. H. Carotenoid composition in Rhinacanthus nasutus (L.) Kurz as determined by HPLC-MS and affected by freeze-drying and hot-air-drying. Analyst 136, 3194–3202 (2011). [DOI] [PubMed] [Google Scholar]
  19. Kao T. H., Chen C. J. & Chen B. H. An improved high performance liquid chromatography-photodiode array detection-atmospheric pressure chemical ionization-mass spectrometry method for determination of chlorophylls and their derivatives in freeze-dried and hot-air-dried Rhinacanthus nasutus (L.) Kurz. Talanta 86, 349–355 (2011). [DOI] [PubMed] [Google Scholar]
  20. Borel P. et al. Interindividual variability of lutein bioavailability in healthy men: characterization, genetic variants involved, and relation with fasting plasma lutein concentration. Am. J. Clin. Nutr. 100, 168–175 (2014). [DOI] [PubMed] [Google Scholar]
  21. Huang Q., Yu H. & Ru Q. Bioavailability and delivery of nutraceuticals using nanotechnology. J. Food Sci. 75, R50–R57 (2010). [DOI] [PubMed] [Google Scholar]
  22. Dolan J. W. Shortcuts for LC measurements. LC-GC 5(12), 1030–1032 (1990). [Google Scholar]
  23. Zhang L. et al. A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int. J. Nanomed. 7, 151–162 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gupta S. S. & Ghosh M. In vitro study of anti-oxidative effects of β -carotene and α -lipoic acid for nanoencapsulated lipids. LWT Food Sci. Technol. 49, 131–138 (2012). [Google Scholar]
  25. Thamaket P. & Raviyan P. Preparation and physical properties of carotenoids encapsulated in chitosan cross-linked tripolyphosphate nanoparticles. Food Appl. Biosci. 3, 69–84 (2015). [Google Scholar]
  26. Xia Q., Xu S. Y. & Zhang X. M. Optimization in the preparation of coenzyme Q10 nanoliposome. J. Agric. Food Chem. 54, 6358–6366 (2006). [DOI] [PubMed] [Google Scholar]
  27. Hsu B. Y., Pu Y. S., Inbaraj B. S. & Chen B. H. An improved high performance liquid chromatography-diode array detection-mass spectrometry method for determination of carotenoids and their precursors phytoene and phytofluene in human serum. J. Chromatogr. B 899, 36–45 (2012). [DOI] [PubMed] [Google Scholar]
  28. Boileau A., Merchen N. R., Wasson K., Atkinson C. A. & Erdman J. W. Cis-lycopene is more bioavailable than trans-lycopene in vitro and in vivo in lymph-cannulated ferrets. J. Nutr. 129, 1176–1181 (1999). [DOI] [PubMed] [Google Scholar]
  29. Stahl W. & Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J. Nutr. 122, 2161–2166 (1992). [DOI] [PubMed] [Google Scholar]
  30. Diwadkar-Navsariwala V. et al. A physiological pharmacokinetic model describing the deposition of lycopene in healthy men. J. Lipid Res. 44, 1927–1939 (2003). [DOI] [PubMed] [Google Scholar]
  31. Salvia-Trujillo L., Qian C., Martin-Belloso O. & McClements D. J. Influence of particle size on lipid digestion and beta-carotene bioaccessibility in emulsions and nanoemulsions. Food Chem. 141, 1470–1480 (2013). [DOI] [PubMed] [Google Scholar]
  32. Wang P., Liu H. J., Mei X. Y., Nakajima M. & Yin L. J. Preliminary study into the factors modulating β -carotene micelle formation in dispersions using an in vitro digestion model. Food Hydrocoll. 26, 427–433 (2012). [Google Scholar]
  33. van het Hof K. H. et al. Bioavailability of lutein from vegetables is 5 times higher than that of beta-carotene. Am. J. Clin. Nutr. 70, 261–268 (1999). [DOI] [PubMed] [Google Scholar]
  34. Hatanaka J. et al. Physicochemical and pharmacokinetic characterization of water-soluble coenzyme Q(10) formulations. Int. J. Pharm. 363, 112–117 (2008). [DOI] [PubMed] [Google Scholar]
  35. Kotyla T., Kuo F., Moolchandani V., Wilson T. & Nicolosi R. Increased bioavailability of a transdermal application of a nano-sized emulsion preparation. Int. J. Pharm. 347, 144–148 (2008). [DOI] [PubMed] [Google Scholar]
  36. Choi H. S., Liu W., Misra P., Tanaka E., Zimmer I. P. & Itty B. Renal clearance of quantum dots. Nature Biotechnol. 25, 1165–1170 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Gupta A. K. & Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995–4021 (2005). [DOI] [PubMed] [Google Scholar]
  38. Inbaraj B. S. et al. Determination of carotenoids and their esters in fruits of Lycium barbarum Linnaeus by HPLC-DAD-APCI-MS. J. Pharm. Biomed. Anal. 47, 812–818 (2008). [DOI] [PubMed] [Google Scholar]
  39. Loh C. H., Inbaraj B. S., Liu M. H. & Chen B. H. Determination of chlorophylls in Taraxacum formosanum by high-performance liquid chromatography-diode array detection-mass spectrometry and preparation by column chromatography. J. Agri. Food Chem. 60, 6108–6115 (2012). [DOI] [PubMed] [Google Scholar]
  40. Chang H. B. & Chen B. H. Inhibition of lung cancer cells A549 and H460 by curcuminoid extracts and nanoemulsions prepared from Curcuma longa Linnaeus. Int. J. Nanomedicine 10, 5059–5080 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. American Psychological Association (APA). Guidelines for ethical conduct in the care and use of nonhuman animals in research, APA Council of Representatives, Office of Research Ethics, Washington DC, USA, 2012. [Google Scholar]
  42. Statistical Analysis System (SAS), SAS procedures and SAS/graph user’s guide, version 6. Cary, NC, USA: SAS Institute, Inc., 2014. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information
srep25426-s1.doc (881.5KB, doc)

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES